There is one clinical trial.

Clinical Trials

1 Monitoring of Lung Fluid Status of Hospitalized COVID-19 Patients by Lung Impedance Technique

COVID 19 is a novel and severe disease. One of the problems is that the virus disturbs the lungs and cause water accumulation in lungs alveolus (ARDS). Today, a chest X-ray is the only practical way to check the degree of lung accumulation. However, X-Ray has many limitations and disadvantages. Lung impedance technology allows simple lung fluid monitoring, and found to be effective in HF patients who suffer from a similar problem. The study's aim is to establish a correlation between lung fluid assessed by impedance technique and x-ray examinations. To find a correlation between lung fluid assessment by impedance and clinical parameters of COVID 19 patients.

NCT04406493 ARDS COVID Diagnostic Test: Lung impedance technique

No related HPO nodes (Using clinical trials)